Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Avanos Medical, Inc. (AVNS) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Avanos Medical, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1606498.
Total stock buying since 2015: $1,871,890.
Total stock sales since 2015: $259,858.
Total stock option exercises since 2015: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 60,000 | $659,100 | 7,000 | $106,778 | 57,598 | $0 |
| 2024 | 0 | $0 | 8,000 | $153,080 | 22,571 | $0 |
| 2021 | 5,000 | $158,190 | 0 | $0 | 0 | $0 |
| 2020 | 10,000 | $287,500 | 0 | $0 | 0 | $0 |
| 2019 | 3,500 | $139,825 | 0 | $0 | 0 | $0 |
| 2018 | 6,500 | $286,675 | 0 | $0 | 0 | $0 |
| 2015 | 11,000 | $340,600 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 60,000 | $659,100 | 0 | $0 | 0 | $0 |
| 2025-03 | 0 | $0 | 7,000 | $106,778 | 57,598 | $0 |
| 2024-03 | 0 | $0 | 8,000 | $153,080 | 22,571 | $0 |
| 2021-09 | 5,000 | $158,190 | 0 | $0 | 0 | $0 |
| 2020-05 | 10,000 | $287,500 | 0 | $0 | 0 | $0 |
| 2019-05 | 3,500 | $139,825 | 0 | $0 | 0 | $0 |
| 2018-11 | 6,500 | $286,675 | 0 | $0 | 0 | $0 |
| 2015-09 | 11,000 | $340,600 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-13 | Blackford Gary (Director) | Buy | 60,000 | 10.98 | 659,100 |
| 2025-03-06 | Holbrook Kerr (SVP, Chief Commercial Officer) | Sale | 7,000 | 15.25 | 106,778 |
| 2025-03-04 | Hurley John Joseph (Principal Accounting Officer) | Option Ex | 107 | .00 | 0 |
| 2025-03-04 | James Mojirade (SVP, General Counsel) | Option Ex | 8,039 | .00 | 0 |
| 2025-03-04 | Holbrook Kerr (SVP, Chief Commercial Officer) | Option Ex | 5,145 | .00 | 0 |
| 2025-03-04 | Woody Joseph Fralin (Other) | Option Ex | 32,158 | .00 | 0 |
| 2025-03-04 | Greiner Michael (Interim CEO) | Option Ex | 12,149 | .00 | 0 |
| 2024-03-18 | Holbrook Kerr (SVP, Chief Commercial Officer) | Option Ex | 2,531 | .00 | 0 |
| 2024-03-18 | Woody Joseph Fralin (Chief Executive Officer) | Option Ex | 15,821 | .00 | 0 |
| 2024-03-18 | Greiner Michael (SVP - Chief Financial Officer) | Option Ex | 4,219 | .00 | 0 |
| 2024-03-14 | Greiner Michael (SVP - Chief Financial Officer) | Sale | 8,000 | 19.14 | 153,080 |
| 2021-09-15 | Oleary Patrick J | Buy | 5,000 | 31.64 | 158,190 |
| 2020-05-08 | Blackford Gary | Buy | 10,000 | 28.75 | 287,500 |
| 2019-05-30 | Woody Joseph Fralin (Chief Executive Officer) | Buy | 3,500 | 39.95 | 139,825 |
| 2018-11-28 | Woody Joseph Fralin (Chief Executive Officer) | Buy | 3,500 | 43.35 | 151,725 |
| 2018-11-27 | Voskuil Steven E (SVP, Chief Financial Officer) | Buy | 2,000 | 43.73 | 87,470 |
| 2018-11-19 | Wesley John W (SVP, General Counsel) | Buy | 1,000 | 47.48 | 47,480 |
| 2015-09-04 | Abernathy Robert E (Chairman and CEO) | Buy | 10,000 | 31.06 | 310,600 |
| 2015-09-01 | Voskuil Steven E (SVP, Chief Financial Officer) | Buy | 1,000 | 30.00 | 30,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of AVNS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Avanos Medical, Inc. (symbol AVNS, CIK number 1606498) see the Securities and Exchange Commission (SEC) website.